Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will...
With the recent introduction of several novel oral...

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the...
July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits...
July 7, 2016 — AtriCure Inc. announced the first patient has been enrolled in the FROST study at William Beaumont...
July 5, 2016 — AtriCure Inc. announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA...

An example of the new generation of cardiac monitoring device that is replacing Holter monitoring is the Cardea Solo wearable sensor. The FDA-cleared device automatically analyzes data when the device is turned back into the physician's office and automatically produces a draft summary report. This technology can simplify the workflow by eliminating the need for third-party involvement.
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time...
June 28, 2016 — New research shows patients admitted to National Health Service (NHS) hospitals in the United...
June 24, 2016 — More than 1 in 3 ...
June 2, 2016 — Female atrial...
There is a movement toward real-time, remote cardiac monitoring with the latest generation of...
May 25, 2016 — Technavio’s latest report on the U.S....
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater...
May 19, 2016 — Physician-researchers in the College of Medicine at the University of Cincinnati have developed a...

New cardiac monitoring technologies allow for longer duration data collection. The Medtronic Reveal Linq implantable cardiac monitor allows for 24/7 monitoring for up to three years. This might not be necessary for most patients, and there are several newer Holter monitors that can record up to several days or several weeks of data in real-time.
New patient monitoring technologies with wireless connectivity have enabled a revolution in cardiac event and...
May 19, 2016 — St. Jude Medical Inc. announced results from two cardiovascular clinical trials presented at EuroPCR...
May 16, 2016 — Tricuspid...
May 11, 2016 — Patients with Wolff-Parkinson-White syndrome who receive...